Metformin’s Potential Role in Posterior Capsule Opacification - Summary - MDSpire

Metformin’s Potential Role in Posterior Capsule Opacification

Common diabetes therapy reaches intraocular lens tissue and may help limit PCO, says newly published data

  • March 30, 2026

  • 3 min

Share

Objective:

To investigate the role of metformin in reducing posterior capsule opacification (PCO) after cataract surgery.

Key Findings:
  • Metformin was detectable in all excised lens capsule specimens, with capsule and serum concentrations significantly correlated.
  • Capsule concentrations did not differ significantly between low-dose and high-dose groups.
  • Metformin treatment significantly attenuated LEC proliferation in vitro compared to controls.
Interpretation:

The findings suggest that metformin may play a protective role against PCO by suppressing LEC proliferation, potentially explaining conflicting epidemiological data regarding diabetes and PCO risk.

Limitations:
  • The study involved a small sample size of 20 patients.
  • Variability in serum levels of metformin may affect generalizability.
Conclusion:

The study provides evidence that metformin accumulates in the human lens capsule and suppresses LEC proliferation, warranting larger studies to further explore its potential as a pharmacological adjunct in PCO prevention.

Original Source(s)

Metformin’s Potential Role in Posterior Capsule Opacification

  • March 30, 2026

Related Content

Advanced bilateral glaucoma decades after first-generation Fyodorov ‘collar-button’ anterior–posterior phakic intraocular lens implantation: a case report and clinical management considerations

Update on Diabetic Disease

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

The Myopia Control Kit

Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.